StemCells, Inc.

StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.[1][2]

StemCells, Inc.
Public
IndustryBiotechnology
Headquarters
Palo Alto 
,
United States of America 
Key people
Ian Massey (CEO)
Irving L. Weissman, M.D. (Founder)
Websitewww.stemcellsinc.com

They are being studied in early stage trials.[3][4]

On November 28, 2016, StemCells merged with Microbot Medical Ltd. and became Microbot Medical Inc.

In March 2020, Microbot Medical Inc. announced the appointment of Eyal Morag, M.D. to Chief Medical Officer.[5]

References
  1. Falco, Miriam. (Sept. 7, 2012). "A tiny step forward for spinal cord injuries."
  2. Le Roux, Mariette. (March 5, 2014). "Science sees future beyond Paralympics."
  3. http://www.clinicaltrials.gov/ct2/show/NCT02163876
  4. "StemCells Inc says spinal injury therapy shows promise". Reuters. 2015-11-18. Retrieved 2015-12-23.
  5. "Microbot Medical Appoints Eyal Morag M.D. as Chief Medical Officer". BioSpace. Retrieved 2020-03-03.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.